中华内科杂志最新文献

筛选
英文 中文
[Expert consensus on endocrine hypertension screening (2025 version)]. 【内分泌高血压筛查专家共识(2025年版)】。
中华内科杂志 Pub Date : 2025-04-01 DOI: 10.3760/cma.j.cn112138-20250103-00007
{"title":"[Expert consensus on endocrine hypertension screening (2025 version)].","authors":"","doi":"10.3760/cma.j.cn112138-20250103-00007","DOIUrl":"10.3760/cma.j.cn112138-20250103-00007","url":null,"abstract":"<p><p>Endocrine hypertension is a common form of secondary hypertension. Affected patients often present without specific symptoms or signs, making the condition easy to overlook or misdiagnose. Early screening can greatly enhance the level of diagnosis while prompt treatment can improve the prognosis of patients. Based on clinical evidence and practice, the Chinese Endocrinologist Association and the Chinese Endocrine Hypertension Collaboration Group reached this consensus after extensive discussions on target populations, screening methods, interpretation of screening results, and other issues related to endocrine hypertension.</p>","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"64 4","pages":"288-301"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143756182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research progress of galectins family in rheumatoid arthritis]. 类风湿关节炎中凝集素家族的研究进展
中华内科杂志 Pub Date : 2025-04-01 DOI: 10.3760/cma.j.cn112138-20241118-00762
X Y Ai, J W Guo, Y L Chen, J Y Xie, X P Hong, D Z Liu
{"title":"[Research progress of galectins family in rheumatoid arthritis].","authors":"X Y Ai, J W Guo, Y L Chen, J Y Xie, X P Hong, D Z Liu","doi":"10.3760/cma.j.cn112138-20241118-00762","DOIUrl":"10.3760/cma.j.cn112138-20241118-00762","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"64 4","pages":"373-376"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143756194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Role of cumulative hemoglobin A1c levels and insulin doses in insulin resistance-related metabolic disorders in patients with type 1 diabetes]. [累积血红蛋白A1c水平和胰岛素剂量在1型糖尿病患者胰岛素抵抗相关代谢紊乱中的作用]。
中华内科杂志 Pub Date : 2025-04-01 DOI: 10.3760/cma.j.cn112138-20241117-00761
M Shi, Y Zhang, W Q Fan, Y Chen, Y T Xie, C Deng, X Li
{"title":"[Role of cumulative hemoglobin A<sub>1c</sub> levels and insulin doses in insulin resistance-related metabolic disorders in patients with type 1 diabetes].","authors":"M Shi, Y Zhang, W Q Fan, Y Chen, Y T Xie, C Deng, X Li","doi":"10.3760/cma.j.cn112138-20241117-00761","DOIUrl":"10.3760/cma.j.cn112138-20241117-00761","url":null,"abstract":"<p><p><b>Objective:</b> To examine the effect of cumulative hemoglobin A<sub>1c</sub> (HbA<sub>1c</sub>) levels and insulin dosage on insulin resistance (IR)-related metabolic disturbances in newly diagnosed patients with type 1 diabetes (T1D). <b>Methods:</b> This retrospective cohort study included T1D patients admitted to the Second Xiangya Hospital of Central South University from November 2015 to March 2023. Clinical data collected comprised age, sex, disease duration, insulin dosage, body mass index, waist circumference, blood pressure, HbA<sub>1c</sub> levels, islet autoantibodies, and fasting blood lipid profiles. IR-related metabolic disturbances assessed were overweight, obesity, central obesity, hypertension, and dyslipidemia. Cox regression and cluster analyses were applied to assess the influence of cumulative HbA<sub>1c</sub> and insulin dosage on these metabolic disturbances. <b>Results:</b> A total of 235 patients were included, with 97 males (41.3%) and 138 females (58.7%). The median age was 19.8 (13.3, 31.1) years, and the median follow-up duration was 30.8 (20.8, 45.6) months. During follow-up, 41.6% (72/173) of patients developed IR-related metabolic disturbances. Multivariate Cox regression analysis revealed that a cumulative HbA<sub>1c</sub> ≥60 mmol/mol was an independent risk factor for any IR-related metabolic disturbance [<i>HR</i> (95%<i>CI</i>): 1.739 (1.067-2.835) ] and for triglyceride abnormalities [<i>HR</i> (95%<i>CI</i>): 3.277 (1.176-9.127)]. Additionally, a cumulative insulin dosage ≥0.5 U·kg<sup>-1</sup>·d<sup>-1</sup> was identified as an independent risk factor for overweight, obesity, or central obesity [<i>HR</i> (95%<i>CI</i>): 2.374 (1.059-5.323)]. Cluster analysis further identified that patients with higher levels of cumulative HbA<sub>1c</sub> and insulin dosage, particularly those with adolescent-onset diabetes, had the highest likelihood of developing hypertension (<i>HR</i>=2.460, 95%<i>CI</i> 1.008-6.005), overweight/obesity/central obesity (<i>HR</i>=2.707, 95%<i>CI</i> 1.062-6.900), triglyceride abnormalities (<i>HR</i>=5.495, 95%<i>CI</i> 1.842-16.391), high-density lipoprotein cholesterol abnormalities (<i>HR</i>=11.054, 95%<i>CI</i> 4.107-29.751), and any IR-related metabolic disturbance (<i>HR</i>=5.833, 95%<i>CI</i> 2.602-13.077). <b>Conclusions:</b> Elevated cumulative HbA<sub>1c</sub> and insulin dosage levels in T1D patients are associated with an increased risk of developing IR-related metabolic disturbances. These findings underscore the urgent need for novel therapeutic strategies tailored to this population.</p>","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"64 4","pages":"309-317"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143756205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Screening for Fabry disease in patients with kidney disease]. [对患有肾脏疾病的患者进行法布里病的筛查]。
中华内科杂志 Pub Date : 2025-04-01 DOI: 10.3760/cma.j.cn112138-20240804-00490
C Yu, Z Li, R Wang, Y M Zhou
{"title":"[Screening for Fabry disease in patients with kidney disease].","authors":"C Yu, Z Li, R Wang, Y M Zhou","doi":"10.3760/cma.j.cn112138-20240804-00490","DOIUrl":"10.3760/cma.j.cn112138-20240804-00490","url":null,"abstract":"<p><p>This study aimed to determine the prevalence of Fabry disease in patients with kidney disease and observe its clinical features. A total of 1 693 patients in the Renal Department of Shandong Provincial Hospital Affiliated to Shandong First Medical University with proteinuria or renal insufficiency were included from June 2020 to December 2023. The α-galactosidase A level in males and globotriaosylsphingosine (Lyso-GL-3) level in females were detected, and GLA gene detection was performed in those with abnormalities. The GLA gene mutation rate was 0.297% (3/1 010) in males, 1.025% (7/683) in females, and 0.591% (10/1 693) overall. The prevalence of Fabry disease was 0.297% (3/1 010) in males, 0.293% (2/683) in females, and 0.295% (5/1 693) overall. The clinical manifestations of Fabry patients with kidney disease are complex and varied, with high heterogeneity. The pathogenicity of GLA gene mutations in patients with kidney disease requires further comprehensive analysis. Some GLA gene mutations are non-pathogenic and are mostly found in females. Patients with primary or secondary kidney disease should not be ignored regarding screening for Fabry disease.</p>","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"64 4","pages":"344-348"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143756208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A case report of VEXAS syndrome]. [VEXAS综合征1例报告]。
中华内科杂志 Pub Date : 2025-04-01 DOI: 10.3760/cma.j.cn112138-20240520-00326
P Song, Z Yao
{"title":"[A case report of VEXAS syndrome].","authors":"P Song, Z Yao","doi":"10.3760/cma.j.cn112138-20240520-00326","DOIUrl":"10.3760/cma.j.cn112138-20240520-00326","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"64 4","pages":"355-357"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143756129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A brief discussion on the standardized management strategy of glucocorticoid withdrawal syndrome]. [浅谈糖皮质激素戒断综合征的规范化管理策略]。
中华内科杂志 Pub Date : 2025-04-01 DOI: 10.3760/cma.j.cn112138-20250206-00069
P Pang, Z H Lyu
{"title":"[A brief discussion on the standardized management strategy of glucocorticoid withdrawal syndrome].","authors":"P Pang, Z H Lyu","doi":"10.3760/cma.j.cn112138-20250206-00069","DOIUrl":"10.3760/cma.j.cn112138-20250206-00069","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"64 4","pages":"277-282"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143756122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Microwave ablation for primary hyperparathyroidism related to multiple endocrine neoplasia type 1 in 3 cases of a family]. 【微波消融治疗原发性甲状旁腺功能亢进伴1型多发性内分泌瘤3例】。
中华内科杂志 Pub Date : 2025-04-01 DOI: 10.3760/cma.j.cn112138-20241104-00728
Q Q Lyu, X Han, Y T Zhao, Y Z Zhang, Z W He, Y Xing, C Liu, S H Xu
{"title":"[Microwave ablation for primary hyperparathyroidism related to multiple endocrine neoplasia type 1 in 3 cases of a family].","authors":"Q Q Lyu, X Han, Y T Zhao, Y Z Zhang, Z W He, Y Xing, C Liu, S H Xu","doi":"10.3760/cma.j.cn112138-20241104-00728","DOIUrl":"10.3760/cma.j.cn112138-20241104-00728","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"64 4","pages":"349-354"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143756192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Diagnostic evaluation on bilateral adrenal lesions]. [双侧肾上腺病变诊断评价]。
中华内科杂志 Pub Date : 2025-04-01 DOI: 10.3760/cma.j.cn112138-20241018-00694
P An, K Chen, Y M Mu
{"title":"[Diagnostic evaluation on bilateral adrenal lesions].","authors":"P An, K Chen, Y M Mu","doi":"10.3760/cma.j.cn112138-20241018-00694","DOIUrl":"10.3760/cma.j.cn112138-20241018-00694","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"64 4","pages":"362-367"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143756179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A rare case of monoclonal gammopathy-associated fibrillary glomerulonephritis]. [一例罕见的单克隆伽玛病相关的原纤维性肾小球肾炎]。
中华内科杂志 Pub Date : 2025-04-01 DOI: 10.3760/cma.j.cn112138-20240724-00469
S X Ai, Y B Wen, G Chen, X S Zhao, K Zheng, Y Qin, X M Li
{"title":"[A rare case of monoclonal gammopathy-associated fibrillary glomerulonephritis].","authors":"S X Ai, Y B Wen, G Chen, X S Zhao, K Zheng, Y Qin, X M Li","doi":"10.3760/cma.j.cn112138-20240724-00469","DOIUrl":"10.3760/cma.j.cn112138-20240724-00469","url":null,"abstract":"","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"64 4","pages":"358-361"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143756135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of serum 25-hydroxyvitamin D3 levels and prognosis in patients with amyotrophic lateral sclerosis]. 肌萎缩性侧索硬化症患者血清25-羟基维生素D3水平与预后分析
中华内科杂志 Pub Date : 2025-04-01 DOI: 10.3760/cma.j.cn112138-20240728-00481
H F Wang, H R Wang, Y C Lin, J M Bai, M Li, X S Huang
{"title":"[Analysis of serum 25-hydroxyvitamin D<sub>3</sub> levels and prognosis in patients with amyotrophic lateral sclerosis].","authors":"H F Wang, H R Wang, Y C Lin, J M Bai, M Li, X S Huang","doi":"10.3760/cma.j.cn112138-20240728-00481","DOIUrl":"10.3760/cma.j.cn112138-20240728-00481","url":null,"abstract":"<p><p><b>Objective:</b> To evaluate serum 25-hydroxyvitamin D<sub>3</sub> [25(OH)D<sub>3</sub>] as a potential biomarker for amyotrophic lateral sclerosis (ALS) severity and to identify risk factors influencing ALS prognosis. <b>Methods:</b> This study included 217 ALS patients hospitalized at the Department of Neurology, First Medical Center, Chinese PLA General Hospital, between October 2018 and October 2021, who met the revised El Escorial diagnostic criteria. A cross-sectional analysis assessed differences in clinical indicators-including the ALS Functional Rating Scale-Revised (ALSFRS-R) and forced vital capacity percentage (FVC%)-across different serum 25(OH)D<sub>3</sub> levels. The correlation between 25(OH)D<sub>3</sub> levels and individual ALSFRS-R components was also examined. Conduct a prospective cohort study to identify independent risk factors affecting the survival time of ALS patients. <b>Results:</b> Among three groups categorized by serum 25(OH)D<sub>3</sub> levels, there were significant differences in the proportion of males (<i>χ</i><sup>2</sup>=10.51, <i>P</i><0.05). Serum 25(OH)D<sub>3</sub> levels correlated positively with lower limb function scores in the ALSFRS-R (<i>r</i>=0.05, <i>P</i><0.05), but they were not identified as an independent risk factor for survival (<i>HR</i>=0.98, 95%<i>CI</i> 0.93-1.04, <i>P</i>>0.05). In contrast, delayed diagnosis(<i>HR</i>=0.94, 95%<i>CI</i> 0.89-0.99, <i>P</i><0.05) and reduced FVC%(<i>HR</i>=0.94, 95%<i>CI</i> 0.97-0.99, <i>P</i><0.05) were independent predictors of shorter survival. <b>Conclusion:</b> Serum 25(OH)D<sub>3</sub> levels differ by gender distribution and may be linked to better lower limb function in ALS patients. However, their role in prolonging survival remains uncertain.</p>","PeriodicalId":68309,"journal":{"name":"中华内科杂志","volume":"64 4","pages":"325-332"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143756154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信